In June, Syapse—a company that works with health systems to implement precision medicine across its organizations—took the next step in leading the shift toward precision medicine by launching the Syapse Precision Medicine Council.
In June, Syapse—a company that works with health systems to implement precision medicine across its organizations—took the next step in leading the shift toward precision medicine by launching the Syapse Precision Medicine Council. The council consists of oncology, operations, and research leaders from health systems dedicated to advancing precision medicine through sharing strategies and insights in order to identify best practices.
Dennis Shin, chief commercial officer of Syapse, discussed the formation of the council, how it plans to disrupt the current precision oncology landscape, and what he sees for the future of the council.
To listen, login to the website.
Listen above or through one of these podcast services:
iTunes: http://apple.co/2eYWTss?rel=0"
TuneIn: http://bit.ly/2gv7iwj?rel=0"
Stitcher: http://bit.ly/2gCqtFg?rel=0"
Syapse, Roche Team Up to Advance Precision Medicine in Oncology
Syapse Looks to Expand Precision Medicine Partnerships With New CEO
Oncologists Are Crucial to Advancing Precision Medicine
Precision Health AI Launches Platform to Deliver Data-Driven Insights in Oncology
Using Health IT to Increase Medication Adherence and Enhance Precision Medicine
Read more about Syapse and precision oncology:
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Insurance Gaps Threaten Cancer Treatment Success
July 7th 2025Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and under optimal circumstances, continue to top the list of reasons behind outcomes disparities for patients who have private insurance vs those who remain uninsured.
Read More
How AI Can Address the Troubled Business Model in Oncology
July 7th 2025Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More